New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Vyome Holdings, Inc.

HIND

Healthcare Biotechnology

Vyome Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $319,700.00, up 24.4% from fiscal 2024.

Revenue
+67.6%
EPS
n/m
Free cash flow
n/m

Quarter to September 2026, against a year earlier

1.20 0.25 −17.24%
Market cap
$10.2M
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
—
F-score
4/9
ROIC
0.00%
Net debt / EBITDA
0.5×
Payout ratio
—

What it owns vs. what it owes End of fiscal 2025, Dec 31, 2025

Debt has fallen from $9.9M to $3.6M since FY16. Shareholders’ equity is 57.9% of the balance sheet. What is a balance sheet?

Dec 31, 2025 · total $6.5M

Owns

$1.1MLong-term assets
$456.0KOther short-term assets
$5.0MCash & short-term investments

Funded by

$3.8MShareholders’ equity
$2.7MOther liabilities

Debt is 0.00% of the total; shareholders’ equity 57.9%.

It went from net cash of 83% of assets to net debt of 252% of assets since FY16.

Total assetsNet debt (debt less cash)Net debt ÷ assets (right axis)
Assets and net debt, eight years
FY16FY17FY18FY19FY20FY21FY22FY24
Total assets$79M$53M$30M$20M$37M$53M$11M$1.4M
Net debt (debt less cash)−$66M−$34M−$14M−$13M$9.8M−$23M−$3.8M$3.5M
Net debt ÷ assets (right axis)−83.3%−64.9%−45.4%−63.4%26.4%−42.9%−34.0%252.4%
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
75.48 44.40 23.74 14.06 3.01 22.82 3.96 4.56 0.10 4.98
Receivables
0.52 4.22 0.87 0.29 2.62 2.82 2.18 1.66 0.99 —
Inventory
0.83 1.42 1.58 1.94 2.24 3.00 3.61 3.74 2.46 —
Other current assets
1.24 1.71 2.46 1.96 1.07 1.31 0.17 — 0.08 0.12
Total current assets
78.06 51.76 28.65 18.24 8.94 29.94 9.91 10.30 0.30 5.44
Property, Plant, Equpment (Net)
0.72 1.35 1.74 1.08 0.58 1.45 0.70 0.06 0.06 0.05
Long-term receivables
— — — — — — — — 0.65 0.60
Goodwill and Intangible Assets (Total)
— — — — 27.02 20.83 0.26 — 0.31 0.31
Long Term Assets (Tax, Deferred)
— — — — — — 0.06 0.03 0.02 —
Long-term assets (Other)
— — — 1.08 0.05 0.05 0.05 0.03 0.03 0.07
Total non-current assets
0.72 1.35 1.74 2.16 28.12 22.59 1.23 0.37 1.08 1.06
Total Assets
78.78 53.10 30.39 20.39 37.06 52.53 11.14 10.66 1.38 6.50
Accounts Payable
0.60 1.28 1.16 0.65 3.66 3.47 1.93 1.69 0.97 1.29
Accrued Expenses
2.50 4.49 3.81 0.82 3.63 3.37 5.04 1.81 0.92 0.87
Current Part of Debt
— 1.96 9.93 0.56 3.61 0.28 0.17 — 3.59 —
Current Revenue (Deferred)
0.12 0.51 0.35 0.42 — — — — — —
Other current liabilities
1.38 1.77 1.99 1.52 0.40 0.42 0.34 0.16 0.11 0.34
Total current liabilities
4.59 10.01 17.23 3.98 11.61 7.53 7.48 3.78 5.74 2.74
Long Term Debt (Total)
9.88 7.96 — 0.57 9.17 — — — — —
Non-current Revenue (Deferred)
— 0.01 0.05 — — — — — — —
Long Term Tax Liability (Deferred)
— — — — 0.62 0.37 — — — —
Non-current Liabilities (Other)
0.00 0.01 0.05 0.00 1.02 0.30 — 0.07 0.02 —
Total non-current liabilities
9.88 7.98 0.05 0.57 10.97 0.67 — 0.22 0.03 —
Total liabilities
14.47 17.99 17.28 4.54 22.57 8.20 7.48 4.00 5.77 2.74
Additional Paid In Capital
140.90 146.47 161.86 188.27 529.43 622.40 627.94 642.33 51.08 90.08
Preferred Stock (Total)
— — — — 0.00 — — — 0.00 —
Common Stock (Net)
0.02 0.02 0.00 0.01 0.00 0.02 0.00 0.02 — 0.01
Retained Earnings
(76.61) (111.37) (148.75) (172.43) (514.83) (577.97) (624.19) (635.57) (55.42) (87.56)
Common Equity (Total)
64.31 35.11 13.11 15.85 14.49 44.33 3.66 6.66 (4.39) 3.76
Shareholders Equity (Total)
64.31 35.11 13.11 15.85 14.49 44.33 3.66 6.66 (4.39) 3.76
Shareholders Equity and Liabilities (Total)
78.78 53.10 30.39 20.39 37.06 52.53 11.14 10.66 1.38 6.50
Shares (Common)
16.77 17.50 2.35 7.72 3.49 0.00 0.00 0.00 0.01 5.92
Shares (Preferred)
— — — — 0.10 0.00 — 0.00 0.00 0.00
Shareholders Equity (Tangible)
64.31 35.11 13.11 15.85 (12.53) 23.51 3.40 6.66 (4.71) 3.45
Net Debt
(65.59) (34.48) (13.80) (12.93) 9.77 (22.54) (3.78) (4.56) 3.49 (4.98)
Total Debt
9.88 9.92 9.93 1.13 12.78 0.28 0.17 — 3.59 —

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026